Notification of Major Interest in Shares

05/05/2009

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

ReGen Therapeutics Plc

2. Reason for the notification:

An acquisition or disposal of voting rights

3. Full name of person(s) subject to the notification obligation (iii):

Barclays PLC

4. Full name of shareholder(s) (if difference from 3):

Barclays Stockbrokers Ltd

5. Date of the transaction and date on which the threshold is crossed or reached (v):

29th April 2009

6. Date on which issued notified:

1st May 2009

7. Threshold(s) that is/are crossed or reached:

10% to 11%

8. Notified details

A: Voting rights attached to shares

Class/type of share if possible using the ISIN Code        GB00B28XMY25

Situation Previous to the triggering transaction (vi) -

Number of Shares                                                    2,593,446

Number of Voting Rights (viii)                                    2,593,446

Resulting situation after the triggering transaction (viii) -

Number of Shares                                                   2,950,942

Number of Voting Rights – Direct (x)                          N/A

Number of Voting Rights – Indirect (xi)                      2,950,942

% of voting rights – Direct                                        N/A

% of voting rights – Indirect                                     10.85

B: Financial Instruments
Resulting situation after the triggering transaction (xii)

Type of financial instrument                           N/A

Expiration date (xiii)                                     N/A

Exercise/Conversion Period/Date (xiv)            N/A

Number of voting rights that may be acquired if the instrument is exercised/converted                                    N/A

% of voting rights                                        N/A
Total (A+B)

Number of voting rights                               2,950,942

% of voting rights                                       11.56
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Barclays Stockbrokers Ltd

Proxy Voting:

10. Name of the proxyholder:                 N/A

11. Number of voting rights proxy holder will cease to hold:                                                     N/A

12. Date on which proxy holder will cease to hold voting
rights:                                                   N/A

13. Additionalinformation:                       N/A

14. Contact name:                                 Geoff Smith

15. Contact telephone number:               0207 116 2913

 

For further information:
For further information, please contact:

Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396